FDA Clears Blood Test for Alzheimer Disease

THURSDAY, Sept. 3, 2026-- The U.S. Food and Drug Administration has cleared the PrecivityAD2 test for adults aged 40 years and older presenting with signs or symptoms of cognitive impairment and undergoing evaluation for Alzheimer disease or other...